CLINICAL_TRIALS
trial_result
· 2021-10-22
Clinical Trial Update: A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma [Phase 1]
Summary
Phase 1 study assessing zanubrutinib in Chinese participants with B-cell lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BeiGene | Conditions: B-cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2021-10-22